Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Monkeypox clade IIb in France in 2023-2024.
Rahi M, Fouere S, Gilbert M, Bachelard A, Taieb F, Sellem B, Herms F, Cazanave C, Valin N, Monsel G, Yazdanpanah Y, Ghosn J, Peiffer-Smadja N; MPV 23-24 Study group. Rahi M, et al. Lancet Reg Health Eur. 2024 Oct 25;47:101114. doi: 10.1016/j.lanepe.2024.101114. eCollection 2024 Dec. Lancet Reg Health Eur. 2024. PMID: 39526296 Free PMC article. No abstract available.
Correction: Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: model of chronic myeloid leukemia treated with tyrosine kinase inhibitors (BIO-TIMER trial).
Casile M, Albrand G, Lahaye C, Lebecque B, Besombes J, Bourgne C, Pereira B, Saugues S, Jamot C, Hermet E, Berger MG. Casile M, et al. Among authors: besombes j. BMC Cancer. 2024 Jul 5;24(1):806. doi: 10.1186/s12885-024-12592-0. BMC Cancer. 2024. PMID: 38970049 Free PMC article. No abstract available.
Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: model of chronic myeloid leukemia treated with tyrosine kinase inhibitors (BIO-TIMER trial).
Casile M, Albrand G, Lahaye C, Lebecque B, Besombes J, Bourgne C, Pereira B, Saugues S, Jamot C, Hermet E, Berger MG. Casile M, et al. Among authors: besombes j. BMC Cancer. 2024 May 30;24(1):661. doi: 10.1186/s12885-024-12415-2. BMC Cancer. 2024. PMID: 38816821 Free PMC article.
Oxidative potential of particulate matter and its association to respiratory health endpoints in high-altitude cities in Bolivia.
Borlaza-Lacoste L, Mardoñez V, Marsal A, Hough I, Dinh VNT, Dominutti P, Jaffrezo JL, Alastuey A, Besombes JL, Močnik G, Moreno I, Velarde F, Gardon J, Cornejo A, Andrade M, Laj P, Uzu G. Borlaza-Lacoste L, et al. Among authors: besombes jl. Environ Res. 2024 Aug 15;255:119179. doi: 10.1016/j.envres.2024.119179. Epub 2024 May 18. Environ Res. 2024. PMID: 38768882
Faster clinical decisions in B-cell acute lymphoblastic leukaemia: A single flow cytometric 12-colour tube improves diagnosis and minimal residual disease follow-up.
Lebecque B, Besombes J, Dannus LT, De Antonio M, Cacheux V, Grèze V, Montagnon V, Veronese L, Tchirkov A, Tournilhac O, Berger MG, Veyrat-Masson R. Lebecque B, et al. Among authors: besombes j. Br J Haematol. 2024 May;204(5):1872-1881. doi: 10.1111/bjh.19390. Epub 2024 Mar 3. Br J Haematol. 2024. PMID: 38432068
50 results